The iShares Biotechnology ETF (IBB) provides exposure to healthcare innovation with a focus on the biggest firms by market ...

In the second quarter, Tealwood Asset Management Inc. expanded its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by ...

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable ...

Despite the new 100% US tariff on imported drugs, China’s biotech firms face minimal impact thanks to licensing deals and ...

Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, ...

Korean pharmaceutical and biotech companies are on edge after U.S. President Donald Trump announced that his administration would impose a 100 percent tariff on imported medicines starting Wednesday.

The company has previously advised that it does not anticipate a material impact from that (10%) tariff. On behalf of our U.S ...

Asian markets opened cautiously on Friday after US President Donald Trump announced a fresh set of tariffs, while investors ...

Drug stocks are celebrating in the wake of Trump's threat to levy a 100% tariff on pharmaceutical imports starting Wednesday.

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, ...

Now, it’s worth noting Stock Advisor’s total average return is 1,062% — a market-crushing outperformance compared to 189 % ...

Explore Terns Pharmaceuticals' obesity and oncology pipeline, strong cash position, and speculative HOLD rating.